Artificial Intelligence in Clinics: Shaping the Future of Diagnostics - ResearchAndMarkets.com

DUBLIN: The "Smart In-Vitro Diagnostics Market - Artificial Intelligence for IVD Markets by Application, Technology and User, with Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offering.

Will Smart Diagnostics replace the physician? Will the power of Artificial Intelligence provide better diagnostics?

The market is moving out of a research mode into the clinic. The market is exploding as physicians use all the information they can get to battle disease. While Pharmaceutical Companies see the potential to make nearly any therapy viable. Find out how this new approach to diagnostics will change medical care forever.

Learn all about how players are jockeying for position in a market that is being created from scratch - and some players are pulling way out in front and expanding globally. It is a dynamic market situation with enormous opportunity where the right diagnostic with the right support can command premium pricing - and the science is developing at the same time creating new opportunities with regularity - and the cost of many diagnostics continues to fall.

This report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of United States Medicare Fee Payment Schedules to help understand the new pricing for nucleic acid-based tests.

• Forecast demand for new testing regimes or technologies.
• Make research investment decisions.
• Assistance in providing specific growth and market size estimates for new technology tests is provided without additional charges.
• Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth.

The report includes detailed breakouts for 18 countries and 4 regions.

Key Topics Covered:

1 Market Guides

1.1 Strategic Situation Analysis

1.2 Guide for Executives, Marketing, and Business Development Staff

1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition

2.1 What are Smart Diagnostics?

2.2 Market Definition

2.3 Methodology

2.4 Perspective: Healthcare and the IVD Industry

3 Market Overview

3.1 Players in a Dynamic Market

3.2 Understanding Artificial Intelligence

3.3 AI Applications in IVD

3.3.1 Infectious Disease

3.3.2 Oncology

3.3.3 Anatomic Pathology

3.3.4 Cardiology

3.3.5 Diabetes

3.3.6 General Medicine

4 Market Trends

4.1 Factors Driving Growth

4.1.1 Outcome Improvement

4.1.2 The Aging Effect

4.1.3 Cost Containment

4.1.4 Physician Impact

4.1.5 Cost of Intelligence

4.2 Factors Limiting Growth

4.2.1 State of knowledge

4.2.2 Genetic Blizzard

4.2.3 Protocol Resistance

4.2.4 Regulation and coverage

4.3 Instrumentation, Automation and Diagnostic Trends

4.3.1 Traditional Automation and Centralization

4.3.2 The New Automation, Decentralization and Point Of Care

4.3.3 Instruments Key to Market Share

4.3.4 Bioinformatics Plays a Role

4.3.5 PCR Takes Command

4.3.6 Next Generation Sequencing Fuels a Revolution

4.3.7 NGS Impact on Pricing

4.3.8 Whole Genome Sequencing, A Brave New World

4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment

4.3.10 Shifting Role of Diagnostics

5 Recent Developments

• Ataraxis AI Launches AI Cancer Dx
• Tempus Immuno-Oncology Portfolio AI-enabled
• AI enables precision diagnosis of cervical cancer
• UK to Rollout Digital Pathology Across NHS
• AI Based Next-Generation Colorectal Cancer Test
• Evident, Corista, Sakura Finetek, Visiopharm Form Digital Pathology Alliance
• Viome Life Sciences Raises $86.5M in Oversubscribed Series C Round
• Becton Dickinson Gets Clearance for AI-Based Bacterial Imaging
• Paige, Leica Biosystems Expand Digital Pathology Partnership
• Clarapath Acquires Digital Pathology Company Crosscope
• CanSense to Develop Colorectal Cancer Test
• Owkin-led Machine Learning Study IDs Cancer Treatment Biomarkers
• Guardant Health to Integrate Lunit's AI PD-L1 Algorithm
• Vesale Bioscience to Develop AI Phage Therapy Diagnostic Platform
• Caris Life Sciences To Use AI and Machine Learning
• Numares Health To Develop AI for "Metabolite Constellations"
• Sepsis Testing Startup DeepUll to Use AI for Medical Decisions
• Viome Life Sciences Raises $67M in Series C Financing For AI Cancer Dx
• ADM Diagnostics Wins Grant for Brain Injury Test Development
• Paige to Develop New AI-based Pathology Test
• Aiforia Gains CE-IVD Mark for AI-Powered Histopathology
• Genetic Profiling May Identify Patients Who Do Not Need Radiation Therapy
• Thermo Fisher Introduces Homologous Score for Cancer Profiling
• Genomic Test IDs Cancer Cells Early

6 Profiles of Key Players

• Adaptive Biotechnologies
• Aidoc
• Anumana
• ARUP Laboratories
• Atomwise
• Bayesian Health
• Behold.ai
• BGI Genomics Co. Ltd
• bioMerieux Diagnostics
• Bio-Rad Laboratories, Inc
• Cambridge Cognition
• Cardiologs (Phillips)
• CareDx
• Caris Molecular Diagnostics
• Cleerly
• ClosedLoop AI
• CloudMedX Health
• Deepcell
• Digital Diagnostics
• EKF Diagnostics Holdings
• Freenome
• GE Healthcare
• Glooko
• Idoven
• Illumina
• Infohealth
• Jade
• K Health
• Lunit
• MaxCyte
• Mayo Clinic Laboratories
• Medtronic
• Merative
• Nanox
• NIOX Group
• Niramai Health Analytix
• NVIDIA
• Oncohost
• OraLiva
• Owkin
• Oxford Nanopore Technologies
• Pacific Biosciences
• Paige.AI
• PathAI
• Perthera
• Philips Healthcare
• Prognos
• Qiagen
• Qure.ai
• Renalytix
• Seegene
• Siemens Healthineers
• Sophia Genetics
• Sysmex
• Viz.ai

7 The Global Market for Smart Diagnostics

7.1 Global Market Overview by Country

7.2 Global Market by Application - Overview

7.3 Global Market by Technology - Overview

7.4 Global Market by Place - Overview

8 Global Markets - By Application

8.1 Cancer

8.2 Infectious Disease Testing

8.3 Metabolic Testing

8.4 Cardiac Testing

8.5 Diabetes Testing

8.6 Other Disease Testing

9 Global Markets - By Technology

9.1 NGS Technology

9.2 PCR Technology

9.3 Chemistry/IA Technology

9.4 Pathology Technology

9.5 Other Technology

10 Global Markets - By Place

10.1 Research

10.2 Pharmaceutical Research

10.3 Clinical

10.4 Other Place

11 Appendices

11.1 United States Clinical Laboratory Fees Schedule

11.1.1 Laboratory Fees Schedule

11.1.2 The Most Used IVD Assays

11.1.3 The Highest Grossing Assays

For more information about this report visit https://www.researchandmarkets.com/r/yrwoev

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Fonte: Business Wire